D. Reske

526 total citations
18 papers, 264 citations indexed

About

D. Reske is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, D. Reske has authored 18 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 10 papers in Neurology and 6 papers in Rheumatology. Recurrent topics in D. Reske's work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (9 papers) and Systemic Lupus Erythematosus Research (4 papers). D. Reske is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (9 papers) and Systemic Lupus Erythematosus Research (4 papers). D. Reske collaborates with scholars based in Germany, Austria and United States. D. Reske's co-authors include H.-F. Petereit, A. Rubbert, Wolf–Dieter Heiss, Walter Moeller‐Hartmann, Walter F. Haupt, Hans‐Walter Pfister, Hayrettin Tumani, Dirk Woitalla, F. Markus Leweke and Sven Jarius and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMC Health Services Research and Journal of Neurology.

In The Last Decade

D. Reske

17 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Reske Germany 8 117 69 63 58 49 18 264
P. Vermersch France 8 78 0.7× 85 1.2× 57 0.9× 66 1.1× 19 0.4× 28 247
Marie‐Claude Diemert France 6 43 0.4× 103 1.5× 27 0.4× 69 1.2× 57 1.2× 7 277
Matthew Pugh United Kingdom 13 70 0.6× 37 0.5× 24 0.4× 49 0.8× 73 1.5× 29 328
Ruxandra Ionescu Romania 9 176 1.5× 27 0.4× 15 0.2× 48 0.8× 91 1.9× 37 339
Bruno Gombert France 8 37 0.3× 67 1.0× 36 0.6× 37 0.6× 42 0.9× 16 262
Pavel Hradílek Czechia 9 138 1.2× 16 0.2× 119 1.9× 28 0.5× 23 0.5× 44 277
Dušanka Martinović Kaliterna Croatia 12 136 1.2× 27 0.4× 19 0.3× 37 0.6× 77 1.6× 44 309
Alice Mariottini Italy 12 174 1.5× 19 0.3× 113 1.8× 22 0.4× 62 1.3× 39 325
Réda Garidi France 9 101 0.9× 21 0.3× 97 1.5× 44 0.8× 11 0.2× 16 261
L.C.S. Thuler Brazil 11 50 0.4× 44 0.6× 22 0.3× 48 0.8× 36 0.7× 16 291

Countries citing papers authored by D. Reske

Since Specialization
Citations

This map shows the geographic impact of D. Reske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Reske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Reske more than expected).

Fields of papers citing papers by D. Reske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Reske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Reske. The network helps show where D. Reske may publish in the future.

Co-authorship network of co-authors of D. Reske

This figure shows the co-authorship network connecting the top 25 collaborators of D. Reske. A scholar is included among the top collaborators of D. Reske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Reske. D. Reske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Neuhaus, Oliver, Wolfgang Köhler, Florian Then Bergh, et al.. (2021). Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers. Biomolecules. 11(3). 393–393. 4 indexed citations
3.
Wappler, Frank, et al.. (2015). Malignes neuroleptisches Syndrom. Der Anaesthesist. 64(7). 527–531. 2 indexed citations
4.
Reske, D., Hayrettin Tumani, Sven Jarius, et al.. (2010). Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis. Journal of Neurology. 257(11). 1855–1863. 53 indexed citations
5.
Reske, D., et al.. (2009). Impact of Immunomodulatory Treatment on Leukocyte Cytokine Production in Multiple Sclerosis Patients and Healthy Donors. NeuroImmunoModulation. 16(6). 385–391. 8 indexed citations
6.
Reske, D. & Walter F. Haupt. (2008). Use of rituximab in multiple sclerosis: current progress and future perspectives. Expert Review of Clinical Immunology. 4(5). 573–582. 4 indexed citations
7.
Petereit, H.-F., Walter Moeller‐Hartmann, D. Reske, & A. Rubbert. (2007). Rituximab in a patient with multiple sclerosis - effect on B cells, plasma cells and intrathecal IgG synthesis. Acta Neurologica Scandinavica. 117(6). 399–403. 48 indexed citations
8.
Reske, D., et al.. (2006). Messbarkeit von Fatigue bei multipler Sklerose mithilfe standardisierter Methoden im deutschsprachigen Raum. Fortschritte der Neurologie · Psychiatrie. 74(9). 497–502. 16 indexed citations
9.
Reske, D.. (2006). Gender change and its impact on the course of multiple sclerosis. Acta Neurologica Scandinavica. 0(0). 3023196489–3023196489. 6 indexed citations
10.
Bosche, Bert, Christian Dohmen, Olivier Zaro Weber, et al.. (2006). Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter disease. Acta Neurologica Scandinavica. 113(6). 433–436. 5 indexed citations
11.
Reske, D., et al.. (2005). Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients – follow-up and clinical implications. SHILAP Revista de lepidopterología. 2(1). 3–3. 32 indexed citations
12.
Reske, D., H.-F. Petereit, & Wolf–Dieter Heiss. (2005). Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system - value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurologica Scandinavica. 112(4). 207–213. 39 indexed citations
13.
Petereit, H.-F., D. Reske, Ralf Pukrop, et al.. (2005). No effect of intravenous immunoglobulins on cytokine-producing lymphocytes in secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 12(1). 66–71. 6 indexed citations
14.
Reske, D. & H.-F. Petereit. (2004). Differenzialdiagnose chronisch-entzündlicher Erkrankungen des Zentralnervensystems: Liquordiagnostik und immunologische Parameter. Der Nervenarzt. 75(10). 945–952. 3 indexed citations
15.
Reske, D. & H.-F. Petereit. (2004). Differenzialdiagnose chronisch-entzündlicher Erkrankungen des Zentralnervensystems. Der Nervenarzt. 75(10). 945–952. 4 indexed citations
16.
Reske, D., et al.. (2003). Long-term persisting interferon beta-1b neutralizing antibodies after discontinuation of treatment. Acta Neurologica Scandinavica. 109(1). 66–70. 13 indexed citations
17.
Reske, D., et al.. (2003). The immunomodulatory properties of in vitro immunoglobulins are dose-dependent. Acta Neurologica Scandinavica. 108(4). 267–273. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026